BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Drug Development

  The New England Journal of Medicine Publishes Data From Durata Therapeutics, Inc. ‘s Discover Program

  June 5, 2014

   · 

  1 min read
• Business

  Five Biotechs, Private Investors Launch KPI Therapeutics

  June 5, 2014

   · 

  7 min read
• Biotech Bay

  Bio-Rad Laboratories, Inc. Launches New Reagents For Target-Specific Preamplification Of Limited Templates For Real-Time PCR

  June 5, 2014

   · 

  3 min read
• BioForest

  Its First Drug In Clinic, Kineta Inc. Keeps Raising Cash From Odd Sources

  June 5, 2014

   · 

  1 min read
• BioMidwest

  BiOptix Announces Support For The 9th Annual Next Generation Protein Therapeutics Summit

  June 5, 2014

   · 

  2 min read
• Drug Development

  Ocugen, Inc. Receives Orphan Designation For OCU100 To Treat Retinitis Pigmentosa

  June 5, 2014

   · 

  1 min read
• Pharm Country

  Actinium Pharmaceuticals, Inc. KOL Joseph Jurcic, MD To Discuss The Role Of Actinium’s Alpha-Particle Radiopharmaceuticals In The Treatment Of Leukemia Patients At The 2014 Society of Nuclear Medicine And Molecular Imaging Annual Meeting

  June 5, 2014

   · 

  1 min read
• Business

  Cellectis And Accelera (Nerviano Medical Sciences (NervianoMS)) Sign An Agreement To Complete Preclinical Studies Of Cellectis’ Lead Product Candidate UCART19

  June 5, 2014

   · 

  1 min read
• Drug Development

  Medgenics, Inc. Announces First Patient Implanted In Phase 1/2 Clinical Trial Of MDGN-201 (EPODURE)

  June 5, 2014

   · 

  1 min read